PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 30 filers reported holding PROTARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,451 | -30.1% | 199,671 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $477,214 | -23.6% | 199,671 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $624,970 | +16.8% | 199,671 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $535,118 | -9.5% | 199,671 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $591,000 | +1.0% | 199,671 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $585,000 | -42.6% | 199,671 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $1,020,000 | -24.3% | 199,671 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $1,348,000 | -2.5% | 199,671 | 0.0% | 0.01% | +16.7% |
| Q3 2021 | $1,382,000 | -28.9% | 199,671 | 0.0% | 0.01% | -33.3% |
| Q2 2021 | $1,945,000 | -38.1% | 199,671 | 0.0% | 0.01% | -35.7% |
| Q1 2021 | $3,143,000 | -35.0% | 199,671 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $4,834,000 | +43.9% | 199,671 | 0.0% | 0.02% | +38.5% |
| Q3 2020 | $3,360,000 | -42.6% | 199,671 | 0.0% | 0.01% | -50.0% |
| Q2 2020 | $5,854,000 | – | 199,671 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |